Results 1 to 10 of about 1,906,742 (351)

Evaluating the Safety of Combining Tyrosine Kinase Inhibitors with Anticoagulants in Chronic Myeloid Leukemia: A Systematic Review.

Oncology
Gameil A, Ghasoub R, Jafari N, Shafei L, Benkhadra M, Laws S, Hamad A, Sabet I, Milojkovic D, Fernyhough L.   +9 more
europepmc   +1 more source

Undifferentiated Blast Crisis in Chronic Myeloid Leukaemia: <i>A rarest-of-the-rare complication in a patient on tyrosine kinase inhibitor</i>. [PDF]

Sultan Qaboos Univ Med J
Mishra P, Sharma S.
europepmc   +1 more source

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

Lancet, The, 2005
Linda M Scott, George S Vassiliou, Anthony R Green   +2 more
exaly   +2 more sources

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.

Cancer Cell, 2005
Polycythemia vera (PV), essential thrombocythemia (ET), and myeloid metaplasia with myelofibrosis (MMM) are clonal disorders arising from hematopoietic progenitors.
R. Levine, M. Wadleigh, J. Cools, B. Ebert, G. Wernig, B. Huntly, T. Boggon, I. Wlodarska, Jennifer J. Clark, Sandra A. Moore, Jennifer Adelsperger, Sumin Koo, Jeffrey C. Lee, S. Gabriel, T. Mercher, A. D’Andrea, S. Fröhling, K. Döhner, P. Marynen, P. Vandenberghe, R. Mesa, A. Tefferi, J. Griffin, M. Eck, W. Sellers, M. Meyerson, T. Golub, Stephanie J. Lee, D. Gilliland   +28 more
semanticscholar   +1 more source

Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors.

Journal of Pharmacology and Experimental Therapeutics, 2000
STI571 (formerly known as CGP 57148B) is a protein-tyrosine kinase inhibitor that is currently in clinical trials for the treatment of chronic myelogenous leukemia.
E. Buchdunger, C. Cioffi, N. M. Law, D. Stover, Sayuri Ohno-Jones, B. Druker, N. Lydon   +6 more
semanticscholar   +1 more source

tyrosine kinase

Catalysis from A to Z, 2020

semanticscholar   +1 more source

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells

Nature Medicine, 1996
B. Druker, S. Tamura, E. Buchdunger, S. Ohno, G. Segal, S. Fanning, J. Zimmermann, N. Lydon   +7 more
semanticscholar   +1 more source

Signal transduction by receptors with tyrosine kinase activity.

Cell, 1990
A. Ullrich, J. Schlessinger
semanticscholar   +1 more source

Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium

Nature, 1995
G. Fong, J. Rossant, M. Gertsenstein, M. Breitman   +3 more
semanticscholar   +1 more source